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Abstract
Preterm birth (PTB) is the world’s leading cause of death in children under 5 years. In 2013, over one million out of
six million child deaths were due to complications of PTB. The rate of decline in child death overall has far outpaced
the rate of decline attributable to PTB. Three key reasons for this slow progress in reducing PTB mortality are: (a) the
underlying etiology and biological mechanisms remain unknown, presenting a challenge to discovering ways to
prevent and treat the condition; (ii) while there are several evidence-based interventions that can reduce the risk of PTB
and associated infant mortality, the coverage rates of these interventions in low- and middle-income countries remain
very low; and (c) the gap between knowledge and action on PTB—the “know-do gap”—has been a major obstacle to
progress in scaling up the use of existing evidence-based child health interventions, including those to prevent and
treat PTB.
In this review, we focus on the know-do gap in PTB as it applies to policymakers. The evidence-based approaches to
narrowing this gap have become known as knowledge transfer and exchange (KTE). In our paper, we propose a
research agenda for promoting KTE with policymakers, with an ambitious but realistic goal of reducing the global
burden of PTB. We hope that our proposed research agenda stimulates further debate and discussion on research
priorities to soon bend the curve of PTB mortality.
Background
Preterm birth (PTB)—birth before 37 weeks of gestatio-
n—is the world’s leading cause of death in children
under 5 years. In 2013, over one million out of six million
child deaths were due to complications of PTB [1]. The
rate of decline in child death overall has far outpaced the
rate of decline attributable to PTB. While the average rate
of all-cause, under-five mortality fell by over 4 % each year
between 2000 and 2013, the death rate from prematurity
fell by only an average of about 2 % each year over the
same time period [1].
There are three key reasons for this slow progress in
reducing PTB mortality. First, while many risk factors
for PTB have been identified (Table 1), the underlying
etiology and biological mechanisms remain unknown
[2]. This lack of knowledge presents a major challenge
to discovering ways to prevent the condition and to treat
those infants affected by PTB. Second, while there are
several evidence-based clinical and population-based in-
terventions that can reduce the risk of PTB and associated
infant mortality, the coverage rates of these interventions
in low- and middle-income countries (LMICs) remain
very low [2]. Finally, the gap between knowledge and ac-
tion on PTB—the “know-do gap” [3]—has been a major
obstacle to progress in scaling up the use of existing
evidence-based child health interventions [4], including
those to prevent and treat PTB [5].
The evidence-based approaches to narrowing this gap
have become known as knowledge transfer and exchange
(KTE). Such exchange involves the “synthesis, exchange,
and application of knowledge by relevant stakeholders”
in ways that accelerate the benefits of global and local
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innovation in health [3]. KTE works best when it is nu-
anced in its application and customized to the needs of
its stakeholders.
In PTB, the stakeholders are a diverse group that in-
cludes mothers, fathers, and their babies; doctors, nurses
and other health care providers; community-based orga-
nizations; people researching the causes of PTB and new
ways to prevent and treat its effects; and policymakers.
These policymakers are at local, national and inter-
national levels, including, for example, individuals creat-
ing and enacting health policy in health departments,
ministries of health, and international health agencies.
Policymakers are critical to enacting the ambitious but
realistic goal of reducing the global burden of PTB
because they influence the way resources are used to le-
verage the evidence or the “know” – they are key to
closing the know-do gap because they have control over
the resources that make enacting the evidence possible.
In this paper, we review the literature and recommend a
KTE research agenda that could help policymakers close
these gaps to reduce the burden of PTB.
We begin by examining the state of the current evi-
dence on what works best in KTE with policymakers,
and on the barriers and facilitators to successful up-
take and use of evidence. We then propose a frame-
work for categorizing where the KTE know-do gaps
are positioned in the evidence-to-policy cycle. Finally,
we end by making recommendations for researchers
seeking to close the gaps in order to reduce the burden of
PTB.
KTE with policymakers: a global imperative for
reducing PTB
Over the past few decades, KTE has emerged as a frame-
work to optimize the translation of the best research evi-
dence and authentic stakeholder perspectives into better
health outcomes [6]. KTE with policymakers in particu-
lar is a critical yet understudied area of research. The
intended outcome of KTE is evidence-informed policy-
making (EIP), which can improve health outcomes by
bringing the best-available evidence into health policy
decision-making processes [7]. Greater adoption of evi-
dence into policies is associated with a shift away from
biased, wasteful and irrelevant health policy decisions,
which are too often taken with poor consideration of
local conditions [3]. KTE moves us toward a more trans-
parent, systematic approach, informed by locally-applicable
evidence and made with appropriate engagement of all
stakeholders [8].
This kind of shift is urgently needed to reduce the burden
of PTB. Until recently, PTB was a very low priority on the
global health agenda. However, the new Sustainable Devel-
opment Goal (SDG) for Health, SDG 3, calls for “an end”
to avertable child and neonatal deaths by 2030 [9]. SDG 3
is one of the 17 SDGs adopted by UN member states in
September 2015. Without addressing PTB, such bold post-
2015 goals will be impossible to reach [10]. As Table 1 illus-
trates, a range of evidence-based policies could substantially
reduce PTB mortality if they were truly marshalled. These
policies may target risk factors, such as policies to reduce
smoking in pregnancy, as well as the accessibility, costs and
quality of maternal and newborn care, such as policies to
scale up kangaroo care.
Evidence of successful KTE with policymakers would
include increased rates of adopting evidence-based inter-
ventions (e.g., higher rates of kangaroo baby care, adop-
tion of stricter tobacco control policies, and increased
implementation of antenatal community outreach ser-
vices in LMICs). Successful KTE should also mean that
local knowledge—that is, evidence that is shared by
members of the affected community— is fully integrated
in the decision-making and reflected in policy outcomes.
Empirical research on improving KTE with
policymakers
Facilitators and barriers to KTE
A 2014 systematic review of studies examining facilitators
and barriers to the use of evidence in health policymaking
found 145 separate studies, including 13 systematic reviews
[11]. The most commonly identified factors that facilitate
or obstruct the use of scientific evidence by policymakers
are summarized in Table 2. Most facilitating factors relate
Table 1 PTB risk factors, prevention, and management.
Evidence is summarized in reference [2]
The physiological mechanisms behind PTB remain largely unknown,
although a number of risk factors have been described. Medical risk
factors include infections, non-communicable diseases and their risk
factors (diabetes, hypertension), and multiple pregnancies; social risk
factors include low or high maternal age, poverty, and receiving antenatal
care for the first time at a late stage in the pregnancy; and behavioral risk
factors include tobacco, alcohol, substance use, and stress.
The Born Too Soon report summarized the key evidence-based
interventions for preventing PTB and for reducing mortality among
those born prematurely [2].
Prevention focuses on prenatal care (e.g., education, nutrition, treatment of
sexually transmitted infections, family planning); antenatal care; obstetric
care; and policies to tackle risk factors, such as smoking in pregnancy.
Reducing mortality focuses on newborn care (e.g., feeding, thermal
care); kangaroo care; neonatal resuscitation if needed; management
of complications; and neonatal intensive care, if needed.
Managing preterm labor can both prevent PTB and reduce mortality among
premature babies. Such management includes antenatal corticosteroids;
antibiotics for premature rupture of the membranes; and tocolytics to slow
down preterm labor.
Broader social, financial, agricultural and other policies that are being
investigated for their potential role in reducing the burden of PTB
include measures to improve household food security; conditional cash
transfers to increase patient uptake of services; and performance-based
financing to improve quality of care.
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to optimizing the usability of research findings: making
research evidence easily accessible to policymakers, for
example, through close collaborative relationships with re-
searchers. Commonly identified barriers to the uptake of
evidence by policymakers reflect the opposite: the greatest
barriers are limited access to research evidence and the
lack of “research literacy” among policymakers.
Two key approaches to KTE with policymakers
To our analysis of barriers and facilitators to KTE imple-
mentation, we added an analysis of existing approaches
to EIP. We discovered multiple interventions that hold
promise for efficiently and effectively transferring and
exchanging knowledge about solutions to PTB with
policymakers. These clustered into two groups, which
we label “linear” and “political economy” approaches for
tackling the problem.
The “linear” EIP approach, also known as “getting re-
search into policy” or GRIP, starts from the viewpoint
that there is a gap between the generation of health evi-
dence on PTB and practical policymaking; closing this
“evidence to policy” gap is an important tool for health
improvement [8]. The linear approach assumes that
there is a series of steps—a linear pathway—from gener-
ating research evidence to evidence-informed policy-
making (Fig. 1). This approach is supported by empirical
evidence showing that clear, relevant, and reliable re-
search findings facilitate the use of evidence by policy-
makers [11]. An example of a specific KTE strategy
flowing from this approach is the production by re-
searchers of a short, accessible evidence brief targeting
policymakers that summarizes the results of a systematic
review and discusses potential policy implications [12].
Table 2 Facilitators and barriers to KTE with policymakers
A 2014 systematic review of studies examining facilitators and barriers
to the use of evidence in health policymaking identified 145 studies,
including 13 systematic reviews [11]. The most commonly identified
facilitators to the use of scientific evidence by policymakers are listed
below (n refers to the number of studies that reported any given factor):
• Good availability of and access to research and improved dissemination
of research (n = 63 studies)
• Strong collaboration between researchers and policymakers (n = 49)
• Clear, relevant, and reliable research findings (n = 46)
• Strong personal relationships between researchers and policymakers
(n = 39).
The most commonly identified barriers to the uptake of evidence by
policymakers were:
• Poor availability of and access to research and poor dissemination of
research (n = 63)
• Unclear research findings of little relevance and poor reliability (n = 54)
• Evidence not available at the time when policymakers needed it most,
i.e., the windows of opportunity for getting evidence into policy were
missed (n = 42)
• Lack of research skills among policymakers (n = 26)
• Economic costs involved in dissemination activities (n = 25).
Fig. 1 A “linear” evidence-informed policymaking approach (figure from [8])
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With a linear approach, certain forms of evidence, par-
ticularly systematic reviews and randomized controlled
trials (RCTs), are given high priority, since they are the
most reliable forms of evidence and are least prone to
bias. They are thus positioned at the top of the “hierarchy
of evidence” [13]. Here, the relevant research evidence on
PTB would be collated and appraised, implications for po-
tential policy directions developed, the evidence would be
used to make judgments about the pros and cons of par-
ticular policy options, and then it would “transferred” to
policymakers who are primed to follow up.
This approach would recognize that PTB policymaking
demands different kinds of input from researchers at differ-
ent stages in the policy process. It also raises the possibility
of earlier engagement of policymakers by researchers so
that researchers have a better sense of the types of issues of
most concern to their audience. Early on, policymakers
often want a menu of options, typically with specific infor-
mation on the pros and cons of each option. Later in the
process, they may want technical assistance in drafting and
implementing specific policy choices.
A second approach, the “political economy” approach,
sees both the research process itself and the transfer of re-
search evidence to policy as heavily influenced by compet-
ing economic interests, social values, and power dynamics
[14, 15]. These forces shape the particular research ques-
tions that receive attention and funding, not to mention if
and how scientific evidence from funded research is
brought to bear on the decision-making process. In this
approach, policymaking cannot be reduced to a series of
linear, technically oriented steps because external social
pressures are such powerful drivers. As Barnes and
Parkhurst argue in their critique of linear evidence-to-
policy processes, “decision-making about global health
policy fundamentally involves making choices between,
and allocating resources towards, competing alternatives,
which have different values to society” [14].
The political economy perspective ultimately calls for
a participatory approach to decision making. The very
process of generating scientific evidence, and bringing it
to bear on policy decisions, should involve “setting up a
democratic and deliberative approach, which is inclusive,
explicit, transparent, and accountable to the needs of the
people these decisions affect” [14]. Key components in-
clude [14, 15]:
 using multiple forms of evidence, not just systematic
reviews (e.g., including the “lived experience” of the
populations affected by the policy);
 acknowledging and understanding the political
processes, vested interests, and ethical dimensions
that shape policymaking;
 encouraging scientists and experts to support “open
reflection and debate” about the evidence; and
 encouraging policymakers to routinely question their
own roles, relationships, and values in relation to
their use of research evidence—for example, by
reflecting on whether they include, exclude, or
perhaps do not “hear” different bodies of evidence.
Evidence on the effectiveness of different KTE strategies
targeting policymakers
Our review of the evidence (summarized in Additional
file 1) suggests that empirical research documenting the
effectiveness of KTE with policymakers is sparse. To
date, there have been no relevant randomized trials of
KTE interventions for policymaking. There have, however,
been multiple non-randomized studies of KTE strategies
based mostly on the linear EIP approach, and multiple
systematic reviews of these studies. Six strategies based on
a linear approach that have shown effectiveness are sum-
marized in Table 3 [6–8, 16, 17] (Additional file 1).
Our review also identified two key KTE strategies with
policymakers based on a political economy approach: (i)
the collective impact strategy, which has been used to ad-
dress conditions such as nutritional deficiencies, commu-
nicable diseases, obesity, and substance misuse [18–21],
and (ii) learning collaboratives, which are aimed at creat-
ing sustainable learning partnerships amongst policy-
makers and researchers [22–24]. The existing evidence on
the effectiveness of these two strategies is summarized in
Table 4.
Proposed research agenda for engaging
policymakers in KTE
Underlying principles
Based on our literature review and analyses described
above, we developed a proposed framework to guide con-
sideration of unanswered research questions about the KTE
process for policymaking on PTB. This framework, sum-
marized in Fig. 2, is premised on two general principles:
 Context matters. KTE never happens in a social,
political, and economic vacuum. For example, the
capacity for policymaking will vary according to
all aspects of the local environment, including the
economic, financial, regulatory, and social
environments, which can vary at both local and country
levels. For these reasons, effective KTE cannot
follow a “one size fits all” approach. A key avenue
of research will be to study how the political,
economic, cultural and social environments in
targeted areas come into play in designing effective
KTE interventions and policies to enact them.
 Effective KTE does not stop once the knowledge has
been transferred. Transferring research evidence is
a necessary but insufficient condition for achieving
sustainable impacts on PTB. Sustained follow-up,
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continued engagement with policymakers, and
tracking the fidelity of the evidence-to-policy
process is likely needed to achieve optimal outcomes.
Thus, a key avenue of research should be to study the
required duration of researcher engagement needed
to support “stickiness” and sustainability of knowledge
in policy formation, implementation, and short and
longer term outcomes.
Proposed framework for KTE targeting policymakers
Our proposed KTE research framework incorporates
both the “linear” and “political economy” approaches to
evidence-informed policymaking. Its five components
include: (1) understanding the context for policymaking;
(2) systematically reviewing the evidence that needs to
be transferred in policymakers; (3) using the best-available
KTE strategies for transferring that evidence; (4) ongoing,
post-transfer engagement; and (5) evaluation of whether
evidence shaped policy.
The circular design of the figure underscores the import-
ance of feedback loops and integration of the two ap-
proaches. We recognize that the transfer and exchange of
evidence to and between policymakers is unlikely to follow
the neat, step-by-step pattern and the sequence of steps im-
plied by Fig. 2 (e.g., sometimes research is conducted after
a policy has been instituted). And while the target audience
is clearly policymakers, Fig. 2 acknowledges that other
actors and stakeholders, including families, community
groups and health providers, must be part of the process.
Research questions and methods to optimize KTE
with policymakers
Using our KTE research framework, we offer an initial
“long list” of research questions that could guide refine-
ments in KTE strategies focused on PTB. We also
prioritize those likely to be the most important and im-
pactful, and then we propose appropriate methodological
approaches to tackle each these questions (Table 5).
We conclude that an important early priority is to
gather baseline information across research sites being
studied on: 1) the current “evidence” sources that policy-
makers already use, 2) current policy efforts at tackling
PTB that are already in place, 3) existing perceptions
and misperceptions of the root causes of PTB held by
policymakers, consumers, and providers, 4) prior suc-
cesses with decreasing PTB, and 5) the readiness of pol-
icymakers to review evidence of effective practices.
Qualitative methods, including in-depth interviews and
focus groups, are best suited to capture these baseline
data, as well as content analyses of existing policies and
protocols. Case study designs will further provide oppor-
tunities to understand the complex context of political,
Table 3 Effective KTE strategies with policymakers, based on
the linear EIP approach
There is evidence from systematic reviews to show that the following
six strategies can increase health policymakers’ “intention to act” on the
evidence presented to them [6–8, 16, 17] (Additional file 1):
• Providing policymakers with evidence briefs: short, accessible
summaries of systematic review and local evidence, describing the
context, problem and policy options, and paying attention to issues
such as policy implementation, equity, local applicability and the
quality of the underlying evidence.
• Deliberative dialogues: these are in-person discussions between
researchers and policymakers, typically followed by a year-long
service in which policymakers receive evidence updates; the dialogues
are based on evidence briefs.
• Providing policymakers with systematic review-derived products:
summaries of reviews, overviews of reviews, and policy briefs.
• “One-stop shops” of optimally-packaged online systematic review-
derived products. An example of a one-stop shop is Health Evidence
(www.healthevidence.org), which allows users to find evidence on the
effectiveness of public health interventions; the resource can be
searched by topic (e.g. premature birth, maternal depression, etc.).
• “Rapid response units,” which provide policymakers written summaries,
telephone consultations or in-person consultations about best evidence.
• SUPPORT tools for evidence-informed health policy making. A set of tools
developed by the Supporting Policy Relevant Reviews and Trials (SUPPORT)
project aimed at helping decision makers in health to make decisions
informed by evidence. The tools cover topics such as identifying evidence
needs, finding the evidence, and applying the evidence.
Table 4 KTE strategies with policymakers based on a political economy approach
Strategy Outcome Type of supportive evidence
Collective impact: a collaborative, multi-sectoral approach
to achieving policy change, with five characteristics: “a
common agenda; shared measurement systems, mutually
reinforcing activities, continuous communication, and the
presence of a backbone organization” [21]
Reductions in a wide range of
health-related outcomes, e.g.
obesity, substance use, nutritional
deficiencies [18–21]
While“evidence of the effectiveness of this
approach is still limited” [21], there are now
multiple large case studies suggesting that
multi-sectoral collective impact approaches
can have a larger effect than working in
isolation [18–21]
Learning collaboratives: these bring policymakers together in
an ongoing way to share knowledge about how to improve
a specific health outcome. Common characteristics of learning
collaboratives are:
• An explicit mission
• Routine learning activities (e.g. continuous learning groups)
• Relationship-building (e.g. through social networking)
Modest benefits in improving
quality of care
A systematic review identified 9 studies using
a controlled design (two were RCTs); these
measured the effects of collaboratives on care
processes or care outcomes. The evidence for
quality improvement was “positive but limited
and the effects cannot be predicted with great
certainty” [24]. Other case studies have suggested
positive outcomes [22, 23].
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cultural and economic conditions in a holistic way, while
integrating what is already known through previous re-
search and using between-site comparisons. This “land-
scaping” should also track preliminary specific areas of
concern and interest to policymakers prior to attempting
any interventions.
Once the context and strategies of KTE are understood,
researchers should then focus on evaluation of the effect-
iveness of a KTE strategy. To understand how a KTE strat-
egy has been previously applied, retrospective designs may
work well. The advantage of this type of study is that it pro-
vides an opportunity to explore in-depth the
implementation of a strategy of interest. Randomized con-
trolled trials, the “gold standard” in research, may be diffi-
cult to conduct at a policy level. Randomization can be
helpful if there are enough settings in which the policy
strategy is being considered to warrant this design. When a
policy strategy is being rolled out on a broad level—across
a country for example—KTE strategies could be applied
differentially across local policy decision-making units (e.g.,
at the county or municipal level) and the processes and
outcomes studied and compared. The advantage of well-
designed randomized studies is that they have more power
to causally associate a KTE strategy with a policy change, as
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Fig. 2 KTE research framework for reducing the burden of PTB—targeted at engaging policymakers
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Table 5 Research questions related to improving KTE with policymakers
Goal of the research Research question Examples of studies in different contexts:
Understanding and improving
elements of the context in which
KTE occurs
What are the political, economic, cultural, and social
contextual factors that influence PTBI policymaking?
Compare and contrast the influence that key
stakeholders have had in PTB policy formation
and implementation in developing countries
(for example, Kenya, Uganda) to those in
underserved communities in developed countries
(for example, Fresno, California). Understand how
the social context has influenced the degree to
which stakeholder groups are able to influence
policy formation.
What are the specific barriers and facilitators to the
uptake of evidence by policymakers in the research
site under study?
Qualitative research with policymakers in the research
site under study; document analysis; case studies
In the site being studied, who are the key
policymakers, how much power do they have
to shape policy, and what is their current
position towards PTB?
Stakeholder analysis
In the research site being studied, how much
priority does PTB currently
receive on the health agenda?
Political prioritization analysis e.g., using the Shiffman
and Smith framework for assessing the position of a
health issue on the national policy agenda [25]
How do material conditions in the research sites
under study (e.g., physical safety, access to clean
water, food supply) impact PTB outcomes?
Community-engaged participatory research,
ethnography
What are the most important PTB outcomes for
people living within each research site, and what
are their views on the optimal path forward
for changing policies to affect those outcomes?
Community-engaged participatory research, ethnography
What is the role of community advisory boards (CABs)
in the policy making process? CABs are comprised of
people with diverse characteristics who are linked by
social ties, share common perspectives, and engage
in joint action in geographical locations or settings.
Involving them optimizes the potential for KTE [26, 27]
Qualitative methods
What strategies are associated
with optimal KTE?
In the research sites under study, do evidence briefs for
policymakers on preventing and treating PTB increase
the likelihood that policies will be informed by the
evidence?
Review of existing policy resource materials to examine
how evidence briefs are used and whether they result in
successful outcomes; case studies of examples of previous
policymaker decision making, what evidence was used,
and with what level of success (in the area of PTBI or
parallel areas, e.g., HIV/AIDS); interventional studies that
test whether evidence briefs affect policy decisions
In the research sites under study, could an online “one
stop shop” on evidence-based interventions for PTB
increase the likelihood that policies will be informed
by the evidence?
Landscape analyses of which resources currently exist,
the availability of any repositories of information,
policymaker preference and current use of tools to
assure that this resource is useful and tailored to needs;
interventional studies that test whether “one-stop shops”
affect policy decisions
In the research sites under study, could “deliberative
dialogues” (Table 3) with policymakers on
evidence-based interventions for PTB increase
the likelihood that policies will be informed
by the evidence?
Conduct a randomized study in which some sites are
randomized to participate in a “deliberate dialogue”
(control sites receive an evidence brief (Table 3) but
do not participate in a dialogue about this brief)
In the research sites under study, could “rapid response
services” (Table 3) with policymakers on evidence-based
interventions for PTB increase the likelihood that
policies will be informed by the evidence?
Incorporate a rapid response service as part of the
randomized study mentioned above
In the research sites under study, could capacity
building with policymakers on how to use
evidence increase the likelihood that policies
will be informed by the evidence?
Incorporate capacity building of policy makers as part
of the randomized study
In the research sites under study, could community
engagement tools help policymakers to consider new
perspectives?
Incorporate community engagement as part of the
randomized study
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opposed to changes that resulted from other factors present
in the social, political and economic context.
Conducting an RCT of a policy intervention at the na-
tional level is typically very costly. RCTs would also require
intensive policymaker and citizen engagement (e.g., discus-
sion of evidence, engagement regarding which policy op-
tions to implement, and provision of technical assistance
as policies are operationalized and implemented and roll
out of the policy in an ethical manner). RCTs are probably
most practical when sufficient resources are available. For
example, with adequate funding, an RCT would be a
valuable design to test a “one-stop shop” of information on
PTB, a rapid response team to provide rapid provision of evi-
dence on PTB when policymakers request it, and twinning
policymakers with local technical assistance providers. Such
a trial could help to ascertain the “dosage” of policy maker
engagement to test the question of KTE sustainability.
Conclusion
In this article, we have identified and characterized a set
of important research questions related to KTE with pol-
icymakers that could potentially be used to reduce the
global burden of PTB. We have also proposed some
study ideas and strategies that hold promise for the field.
Discovering the right strategies, or bundles of strategies,
to optimize KTE for this group of stakeholders is crucial
for the success of the PTBI. We hope that our proposed
research agenda stimulates further debate and discussion
on research priorities to soon bend the curve of PTB
mortality.
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Table 5 Research questions related to improving KTE with policymakers (Continued)
In the research sites under study, could the cultivation
of learning collaboratives among policymakers on
evidence-based interventions for PTB increase the
likelihood that policies will be informed by the
evidence?
Incorporate learning collaboratives as part of the
randomized study
What are the best ways to optimize the communication
from CABs to policy makers? [26, 27] What is the role of
advocacy groups?
Participant observation; key informant interviews with
participants
What components of post-transfer
engagement are associated with
KTE strength and durability?
What is the duration of post-transfer engagement that
is needed to support “stickiness” and sustainability of
knowledge transfer?
Monitor and study research sites as part of the
randomized study
What levels of ongoing KTE support were required to
achieve tangible policy change outcomes?
Process evaluation of the KTE efforts
How might one improve KTE to create better sustainability
in post-transfer engagement?
Exit interviews with participants in KTE efforts to assess
“what worked” and “what didn’t”
Evaluation Did policymakers use the evidence transferred? If they
did use it, how did they use the evidence?
Qualitative key informant interviews of how evidence
was used, and surveys of policymakers’ knowledge of
scientific evidence pre/post KTE
Did KTE efforts result in tangible changes in policies
that promote improved PTB outcomes?
Case studies that track KTE from knowledge transfer to
policy drafting and implementation to assess changes
in funding levels, regulations, etc.
Do KTE efforts, when they have successfully informed
policymaking, have a measureable impact on PTB health
outcomes?
Natural experiments, ideally using comparison sites, to
track PTB outcomes before and after evidence-informed
policies were implemented
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